The effects of difumarate salt S-15176 after spinal cord injury in rats

Journal of Korean Neurosurgical Society

Volumn 57, Issue 6, 2015, Pages 445-454

  Erdoğan, Hakan ^a   Tunçdemir, Matem ^b   Kelten, Bilal ^a   Akdemir, Osman ^c   Karaoğlan, Alper ^a   Taşdemiroğlu, Erol ^d  

^a MALTEPE UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c ISTANBUL TRAINING AND RESEARCH HOSPITAL   (Turkey)

^d ME DI ENT Center   (Turkey)

Author keywords

Apoptosis; Caspase 9; Cytochrome c; Difumarate salt (S 15176); Spinal cord injury

Indexed keywords

CASPASE 9; CYTOCHROME C; DIFUMARATE SALT S 15176; NEUROPROTECTIVE AGENT; PROTEIN BAX; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; APOPTOTIC INDEX; ARTICLE; CELL COUNT; CELLULAR PARAMETERS; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOPEROXIDASE STAINING; IMMUNOREACTIVITY; LAMINECTOMY; MALE; MICROSCOPY; MOTOR PERFORMANCE; NONHUMAN; RAT; SPINAL CORD INJURY; TUNEL ASSAY;

EID: 84936745575     PISSN: 20053711     EISSN: 15987876     Source Type: Journal    
DOI: 10.3340/jkns.2015.57.6.445     Document Type: Article

References (57)

1. Albengres E, Le Louët H, d’Athis P, Tillement JP: S15176 and S16950 interaction with Cyclosporin A antiproliferative effect on cultured human lymphocytes. Fundam Clin Pharmacol 15: 41-46, 2001
2. Allen AR: Surgery of experimental lesion of spinal cord equivalent to crush injury of fracture dislocation of spinal column: a preliminary report. JAMA 57: 877-880, 1911
3. Amar AP, Levy ML: Pathogenesis and pharmacological strategies for mitigating secondary damage in acute spinal cord injury. Neurosurgery 44: 1027-1039; discussion 1039-1040, 1999
4. Basso DM, Beattie MS, Bresnahan JC: A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 12: 1-21, 1995
5. Bernardi P: The permeability transition pore. Control points of a cyclosporin A-sensitive mitochondrial channel involved in cell death. Biochim Biophys Acta 1275: 5-9, 1996
6. Bernardi P, Broekemeier KM, Pfeiffer DR: Recent progress on regulation of the mitochondrial permeability transition pore; a cyclosporinsensitive pore in the inner mitochondrial membrane. J Bioenerg Biomembr 26: 509-517, 1994
7. Broekemeier KM, Dempsey ME, Pfeiffer DR: Cyclosporin A is a potent inhibitor of the inner membrane permeability transition in liver mitochondria. J Biol Chem 264: 7826-7830, 1989
8. Chávez E, Rodríguez JS, García G, García N, Correa F: Oligomycin strengthens the effect of cyclosporin A on mitochondrial permeability transition by inducing phosphate uptake. Cell Biol Int 29: 551-558, 2005
9. Cheng H, Cao Y, Olson L: Spinal cord repair in adult paraplegic rats: partial restoration of hind limb function. Science 273: 510-513, 1996
10. Crompton M: The mitochondrial permeability transition pore and its role in cell death. Biochem J 341 (Pt 2): 233-249, 1999
11. Crompton M, Costi A, Hayat L: Evidence for the presence of a reversible Ca2+-dependent pore activated by oxidative stress in heart mitochondria. Biochem J 245: 915-918, 1987
12. Crowe MJ, Bresnahan JC, Shuman SL, Masters JN, Beattie MS: Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat Med 3: 73-76, 1997
13. Dumont RJ, Okonkwo DO, Verma S, Hurlbert RJ, Boulos PT, Ellegala DB, et al.: Acute spinal cord injury, part I: pathophysiologic mechanisms. Clin Neuropharmacol 24: 254-264, 2001
14. Dumont RJ, Verma S, Okonkwo DO, Hurlbert RJ, Boulos PT, Ellegala DB, et al.: Acute spinal cord injury, part II: contemporary pharmacotherapy. Clin Neuropharmacol 24: 265-279, 2001
15. Elimadi A, Jullien V, Tillement JP, Morin D: S-15176 inhibits mitochondrial permeability transition via a mechanism independent of its antioxidant properties. Eur J Pharmacol 468: 93-101, 2003
16. Elimadi A, Sapena R, Settaf A, Le Louet H, Tillement J, Morin D: Attenuation of liver normothermic ischemia--reperfusion injury by preservation of mitochondrial functions with S-15176, a potent trimetazidine derivative. Biochem Pharmacol 62: 509-516, 2001
17. Elimadi A, Settaf A, Morin D, Sapena R, Lamchouri F, Cherrah Y, et al.: Trimetazidine counteracts the hepatic injury associated with ischemiareperfusion by preserving mitochondrial function. J Pharmacol Exp Ther 286: 23-28, 1998
18. Fiskum G: Mitochondrial participation in ischemic and traumatic neural cell death. J Neurotrauma 17: 843-855, 2000
19. Fournier N, Ducet G, Crevat A: Action of cyclosporine on mitochondrial calcium fluxes. J Bioenerg Biomembr 19: 297-303, 1987
20. Friberg H, Ferrand-Drake M, Bengtsson F, Halestrap AP, Wieloch T: Cyclosporin A, but not FK 506, protects mitochondria and neurons against hypoglycemic damage and implicates the mitochondrial permeability transition in cell death. J Neurosci 18: 5151-5159, 1998
21. Geisler FH, Dorsey FC, Coleman WP: Recovery of motor function after spinal-cord injury--a randomized, placebo-controlled trial with GM-1 ganglioside. N Engl J Med 324: 1829-1838, 1991
22. Green DR, Reed JC: Mitochondria and apoptosis. Science 281: 1309-1312, 1998
23. Halestrap AP, Connern CP, Griffiths EJ, Kerr PM: Cyclosporin A binding to mitochondrial cyclophilin inhibits the permeability transition pore and protects hearts from ischaemia/reperfusion injury. Mol Cell Biochem 174: 167-172, 1997
24. Hamburger V: Cell death in the development of the lateral motor column of the chick embryo. J Comp Neurol 160: 535-546, 1975
25. Hamdan M, Urien S, Le Louet H, Tillement JP, Morin D: Inhibition of mitochondrial carnitine palmitoyltransferase-1 by a trimetazidine derivative, S-15176. Pharmacol Res 44: 99-104, 2001
26. Hauet T, Mothes D, Goujon JM, Caritez JC, Carretier M, le Moyec L, et al.: Trimetazidine prevents renal injury in the isolated perfused pig kidney exposed to prolonged cold ischemia. Transplantation 64: 1082-1086, 1997
27. Hu Y, Benedict MA, Ding L, Núñez G: Role of cytochrome c and dATP/ATP hydrolysis in Apaf-1-mediated caspase-9 activation and apoptosis. EMBO J 18: 3586-3595, 1999
28. Joshi DC, Bakowska JC: Determination of mitochondrial membrane potential and reactive oxygen species in live rat cortical neurons. J Vis Exp 23: (51). Pii: 2704, 2011
29. Katoh K, Ikata T, Katoh S, Hamada Y, Nakauchi K, Sano T, et al.: Induction and its spread of apoptosis in rat spinal cord after mechanical trauma. Neurosci Lett 216: 9-12, 1996
30. Kawashima S, Yamamoto T, Horiuchi Y, Fujiwara K, Gouda S, Yoshimura Y, et al.: S-15176 and its methylated derivative suppress the CsA-insensitive mitochondrial permeability transition and subsequent cytochrome c release induced by silver ion, and show weak protonophoric activity. Mol Cell Biochem 358: 45-51, 2011
31. Keane RW, Kraydieh S, Lotocki G, Bethea JR, Krajewski S, Reed JC, et al.: Apoptotic and anti-apoptotic mechanisms following spinal cord injury. J Neuropathol Exp Neurol 60: 422-429, 2001
32. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD: The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275: 1132-1136, 1997
33. Kroemer G, Dallaporta B, Resche-Rigon M: The mitochondrial death/ life regulator in apoptosis and necrosis. Annu Rev Physiol 60: 619-642, 1998
34. Kroemer G, Petit P, Zamzami N, Vayssière JL, Mignotte B: The biochemistry of programmed cell death. FASEB J 9: 1277-1287, 1995
35. Liu XZ, Xu XM, Hu R, Du C, Zhang SX, McDonald JW, et al.: Neuronal and glial apoptosis after traumatic spinal cord injury. J Neurosci 17: 5395-5406, 1997
36. Lu J, Ashwell KW, Waite P: Advances in secondary spinal cord injury: role of apoptosis. Spine (Phila Pa 1976) 25: 1859-1866, 2000
37. Ly JD, Grubb DR, Lawen A: The mitochondrial membrane potential (deltapsi(m)) in apoptosis; an update. Apoptosis 8: 115-128, 2003
38. Morin D, Papadopoulos V, Tillement JP: Prevention of cell damage in ischemia: novel molecular targets in mitochondria. Expert Opin Therap Target 6: 315-334, 2002
39. Morin D, Zini R, Berdeaux A, Tillement JP: Effect of the mitochondrial transition pore inhibitor, S-15176, on rat liver mitochondria: ATP synthase modulation and mitochondrial uncoupling induction. Biochem Pharmacol 72: 911-918, 2006
40. Novgorodov SA, Gudz TI, Brierley GP, Pfeiffer DR: Magnesium ion modulates the sensitivity of the mitochondrial permeability transition pore to cyclosporin A and ADP. Arch Biochem Biophys 311: 219-228, 1994
41. Rupp H, Zarain-Herzberg A, Maisch B: The use of partial fatty acid oxidation inhibitors for metabolic therapy of angina pectoris and heart failure. Herz 27: 621-636, 2002
42. Sayeed I, Parvez S, Wali B, Siemen D, Stein DG: Direct inhibition of the mitochondrial permeability transition pore: a possible mechanism for better neuroprotective effects of allopregnanolone over progesterone. Brain Res 1263: 165-173, 2009
43. Schwab ME, Bartholdi D: Degeneration and regeneration of axons in the lesioned spinal cord. Physiol Rev 76: 319-370, 1996
44. Settaf A, Morin D, Lamchouri F, Elimadi A, Cherrah Y, Tillement JP: Trimetazidine ameliorates the hepatic injury associated with ischaemiareperfusion in rats. Pharmacol Res 39: 211-216, 1999
45. Settaf A, Zahidy M, Elimadi A, Sapena R, Alsamad IA, Tillement J, et al.: S-15176 reduces the hepatic injury in rats subjected to experimental ischemia and reperfusion. Eur J Pharmacol 406: 281-292, 2000
46. Shuman SL, Bresnahan JC, Beattie MS: Apoptosis of microglia and oligodendrocytes after spinal cord contusion in rats. J Neurosci Res 50: 798-808, 1997
47. Sullivan PG, Thompson MB, Scheff SW: Cyclosporin A attenuates acute mitochondrial dysfunction following traumatic brain injury. Exp Neurol 160: 226-234, 1999
48. Tator CH: Biology of neurological recovery and functional restoration after spinal cord injury. Neurosurgery 42: 696-707; discussion 707-708, 1998
49. Tator CH, Fehlings MG: Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J Neurosurg 75: 15-26, 1991
50. Tatton WG, Chalmers-Redman RM: Mitochondria in neurodegenerative apoptosis: an opportunity for therapy? Ann Neurol 44 (3 Suppl 1): S134-S141, 1998
51. Tunçdemir M, Yıldırım A, Karaoğlan A, Akdemir O, Oztürk M: AR A014418 as a glycogen synthase kinase-3 inhibitor: anti-apoptotic and therapeutic potential in experimental spinal cord injury. Neurocirugia (Astur) 24: 22-32, 2013
52. Tunçdemir M, Ozturk M: The effects of ACE inhibitor and angiotensin receptor blocker on clusterin and apoptosis in the kidney tissue of streptozotocin-diabetic rats. J Mol Histol 39: 605-616, 2008
53. Yılmaz MB, Tönge M, Emmez H, Kaymaz F, Kaymaz M: Neuroprotective effects of quetiapine on neuronal apoptosis following experimental transient focal cerebral ischemia in rats. J Korean Neurosurg Soc 54: 1-7, 2013
54. Yong C, Arnold PM, Zoubine MN, Citron BA, Watanabe I, Berman NE, et al.: Apoptosis in cellular compartments of rat spinal cord after severe contusion injury. J Neurotrauma 15: 459-472, 1998
55. Youdim MB, Bar Am O, Yogev-Falach M, Weinreb O, Maruyama W, Naoi M, et al.: Rasagiline: neurodegeneration, neuroprotection, and mitochondrial permeability transition. J Neurosci Res 79: 172-179, 2005
56. Young W: Secondary injury mechanisms in acute spinal cord injury. J Emerg Med 11 Suppl 1: 13-22, 1993
57. Zoratti M, Szabò I: The mitochondrial permeability transition. Biochim Biophys Acta 1241: 139-176, 1995